Goldentree Asset Management Lp

13F Holdings History for Bausch Health Companies Inc. - Common Shares, No Par Value (BHC)

Symbol: BHC on NYSE
Investment type: Equity / Common Shares, No Par Value
Latest Disclosed Ownership: 35.2M shares
Security Ownership: 9.5%

Shares, Excluding Options vs Price

Value, Excluding Options

Steven A. Tananbaum ownership in Bausch Health Companies Inc. Common Shares, No Par Value (BHC)

2025-08-14 - Steven A. Tananbaum has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 35.2M shares of Bausch Health Companies Inc. Common Shares, No Par Value (BHC). This represents 9.5% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Steven A. Tananbaum	9.5%		$267M	35.2M			$7.58	13G/A	6/30/2025	14 Aug 2025 16:05:17

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	22%	+0.37%	$224M	34.8M	+578,542	+1.69%	$6.44	Q3 2025
6/30/2025	22%	+2.57%	$228M	34.3M	+4,004,889	+13.2%	$6.65	Q2 2025
3/31/2025	15.4%	+1.38%	$195M	30.3M	+2,709,925		$6.46	Q1 2025
12/31/2024	17%	-1.15%	$222M	27.5M	-1,855,670	-6.31%	$8.05	Q4 2024
9/30/2024	19.1%	+4.53%	$240M	29.4M	+6,958,717	+31%	$8.15	Q3 2024
6/30/2024	13%	-2.89%	$156M	22.4M	-5,207,931	-18.8%	$6.97	Q2 2024
3/31/2024	23.3%		$293M	27.6M			$10.61	Q1 2024
12/31/2023	23%	+3.1%	$222M	27.6M	+3,657,497	+15.2%	$8.02	Q4 2023
9/30/2023	20.8%	+3.41%	$197M	24M	+3,931,234	+19.6%	$8.22	Q3 2023
6/30/2023	14.6%	+2.56%	$160M	20.1M	+3,523,230	+21.3%	$8.00	Q2 2023
3/31/2023	12.5%	-3.61%	$134M	16.5M	-4,750,711	-22.3%	$8.10	Q1 2023
12/31/2022	10.7%	+2.42%	$134M	21.3M	+4,798,327	+29.1%	$6.28	Q4 2022
9/30/2022	7.51%	+1.1%	$114M	16.5M	+2,411,917	+17.1%	$6.89	Q3 2022
6/30/2022	7.66%	+3.32%	$118M	14.1M	+6,099,491	+76.5%	$8.36	Q2 2022
3/31/2022	8.41%	+2.14%	$182M	7.97M	+2,026,355	+34.1%	$22.85	Q1 2022
12/31/2021	7.15%	-4.08%	$164M	5.95M	-3,394,999	-36.3%	$27.61	Q4 2021
9/30/2021	12.8%	+0.87%	$260M	9.34M	+1,175,857	+14.4%	$27.85	Q3 2021
6/30/2021	10.7%	-0.7%	$239M	8.17M	-421,531	-4.91%	$29.32	Q2 2021
3/31/2021	15.3%	-3.25%	$273M	8.59M	-2,603,061	-23.3%	$31.74	Q1 2021
12/31/2020	9.15%	+3.32%	$233M	11.2M	+4,062,113	+57%	$20.80	Q4 2020
9/30/2020	9.51%	-1%	$111M	7.13M	-730,224	-9.29%	$15.54	Q3 2020
6/30/2020	17.6%	-1.76%	$144M	7.86M	-785,043	-9.08%	$18.29	Q2 2020
3/31/2020	24.8%	+4.25%	$134M	8.64M	+1,480,131	+20.7%	$15.50	Q1 2020
12/31/2019	32%	+1.64%	$214M	7.16M	+367,000	+5.4%	$29.92	Q4 2019
9/30/2019	21.5%	-3.24%	$149M	6.8M	-1,025,215	-13.1%	$21.85	Q3 2019
6/30/2019	22.3%	+8.61%	$197M	7.82M	+3,018,574	+62.8%	$25.22	Q2 2019
3/31/2019	12.8%	+1.69%	$119M	4.8M	+631,800	+15.1%	$24.70	Q1 2019
12/31/2018	12.2%	+4.28%	$77.1M	4.17M	+1,470,919	+54.5%	$18.47	Q4 2018
9/30/2018	4.41%	+4.41%	$69.3M	2.7M	+2,701,298	NEW	$25.67	Q3 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.